Bioequiv.Bioequiv.
HealthyBioequiv.Recruitingํ๊ฒฝ์—ฌ์„ฑ

[ํ๊ฒฝ ์—ฌ์„ฑ๋Œ€์ƒ] ๋‹ค๋ฆผ๋ฐ”์ด์˜คํ… - DLT264

Trial start date
2026.11.28D-10
Trial site์„œ์šธ ๋ถ€๋ฏผ๋ณ‘์› ๋ฏธ๋ž˜์˜ํ•™์„ผํ„ฐ์„œ์šธ ๊ฐ•์„œ๊ตฌ ๊ณตํ•ญ๋Œ€๋กœ 375 1์ธต ์ž„์ƒ์‹œํ—˜์„ผํ„ฐ
Waitlist Available
Screening period2026.10.30 ~ 2026.11.29(Choose date/time when applying)
Trial end date2027.01.06
Trial schedule

[1๊ธฐ] 2๋ฐ• 3์ผ 1ํšŒ + ์™ธ๋ž˜๋ฐฉ๋ฌธ 2ํšŒ
[2๊ธฐ] 2๋ฐ• 3์ผ 1ํšŒ + ์™ธ๋ž˜๋ฐฉ๋ฌธ 2ํšŒ
*1๊ธฐ์™€ 2๊ธฐ ๋ชจ๋‘ ์ฐธ์—ฌ

์ œ 1๊ธฐ

์ž…์›์ผ (-1D)

2026๋…„ 11์›” 29์ผ

(์˜คํ›„ 5์‹œ๊ฒฝ ์ž…์›)

ํˆฌ์•ฝ์ผ (1D)

2026๋…„ 11์›” 30์ผ

(์ž…์› ์ค‘)

ํ‡ด์›์ผ (2D)

2026๋…„ 12์›” 01์ผ

(์˜ค์ „ 8์‹œ๊ฒฝ ์ผ์ • ์ง„ํ–‰ ํ›„ ๊ท€๊ฐ€)

์™ธ๋ž˜๋ฐฉ๋ฌธ์ผ (3D)

2026๋…„ 12์›” 02์ผ

(์˜ค์ „ 7์‹œ 30๋ถ„๊ฒฝ ์™ธ๋ž˜๋ฐฉ๋ฌธ ์ผ์ • ์ง„ํ–‰ ํ›„ ๊ท€๊ฐ€)

์™ธ๋ž˜๋ฐฉ๋ฌธ์ผ (4D)

2026๋…„ 12์›” 03์ผ

(์˜ค์ „ 7์‹œ 30๋ถ„๊ฒฝ ์™ธ๋ž˜๋ฐฉ๋ฌธ ์ผ์ • ์ง„ํ–‰ ํ›„ ๊ท€๊ฐ€)

์ œ 2๊ธฐ

์ž…์›์ผ (-1D)

2027๋…„ 01์›” 03์ผ

(์˜คํ›„ 5์‹œ๊ฒฝ ์ž…์›)

ํˆฌ์•ฝ์ผ (1D)

2027๋…„ 01์›” 04์ผ

(์ž…์› ์ค‘)

ํ‡ด์›์ผ (2D)

2027๋…„ 01์›” 05์ผ

(์˜ค์ „ 8์‹œ๊ฒฝ ์ผ์ • ์ง„ํ–‰ ํ›„ ๊ท€๊ฐ€)

์™ธ๋ž˜๋ฐฉ๋ฌธ์ผ (3D)

2027๋…„ 01์›” 06์ผ

(์˜ค์ „ 7์‹œ 30๋ถ„๊ฒฝ ์™ธ๋ž˜๋ฐฉ๋ฌธ ์ผ์ • ์ง„ํ–‰ ํ›„ ๊ท€๊ฐ€)

์™ธ๋ž˜๋ฐฉ๋ฌธ์ผ (4D)

2027๋…„ 01์›” 07์ผ

(์˜ค์ „ 7์‹œ 30๋ถ„๊ฒฝ ์™ธ๋ž˜๋ฐฉ๋ฌธ ์ผ์ • ์ง„ํ–‰ ํ›„ ๊ท€๊ฐ€)

MediCLEO (CLEO) safely and transparently connects participants with clinical and bioequivalence trials. See ongoing trials at a glance and apply with ease.

์ŠคํŽ˜๋กœ ์ฃผ์‹ํšŒ์‚ฌ ยท CEO ์กฐ๋ฏธํ˜„ ยท ์„œ์šธํŠน๋ณ„์‹œ ๋งˆํฌ๊ตฌ ์–‘ํ™”๋กœ 19, 4์ธต(ํ•ฉ์ •๋™, ํ•ฉ์ •์˜คํ”ผ์Šค๋นŒ๋”ฉ)

Business Registration No. 367-86-01018 ยท Tel 010-2604-0216

ยฉ 2026 ๋ฉ”๋””ํด๋ ˆ์˜ค. Participation in a clinical trial should be decided voluntarily after a full explanation.